|
|
DSpace at RU >
Browsing by Author Thomas, X.
Showing results 1 to 4 of 4
| Full Text | Issue Date | Title | Author(s) | | 2009 | Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10. | Mandelli, F.; Vignetti, M.; Suciu, S.; Stasi, R.; Petti, M.C., et al |
| 2007 | Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study. | Thomas, X.; Suciu, S.; Rio, B.; Leone, G.; Broccia, G., et al |
| 2006 | Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial. | Jehn, U.; Suciu, S.; Thomas, X.; Lefrere, F.; Muus, P., et al |
| 2005 | Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study. | Amadori, S.; Suciu, S.; Jehn, U.; Stasi, R.; Thomas, X., et al |
Showing results 1 to 4 of 4
|